# FDA Inspection 1211246 - Zhejiang Jiangbei Pharmaceutical Co., Ltd. - July 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-jiangbei-pharmaceutical-co-ltd/e7bb5525-30cf-4420-8fd7-e76a707e0050
Source feed: FDA_Inspections

> FDA Inspection 1211246 for Zhejiang Jiangbei Pharmaceutical Co., Ltd. on July 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1211246
- Company Name: Zhejiang Jiangbei Pharmaceutical Co., Ltd.
- Inspection Date: 2023-07-07
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 973552 - 2016-05-06](https://www.keypedia.com/records/fda_inspections/zhejiang-jiangbei-pharmaceutical-co-ltd/a56d2196-5178-4bb1-8914-56460d9b5c60)
- [FDA Inspection 875391 - 2014-04-03](https://www.keypedia.com/records/fda_inspections/zhejiang-jiangbei-pharmaceutical-co-ltd/c9c4822a-997d-44c5-90b8-def7bddf6226)

Company: https://www.keypedia.com/companies/zhejiang-jiangbei-pharmaceutical-co-ltd/c20da6eb-afeb-4319-af1d-fd6d71abbbbd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c